Cargando…

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus

Tacrolimus and Sirolimus are commonly used maintenance immunesuppressants in kidney transplantation. Since their effects on immune cells and allograft molecular profiles have not been elucidated, we characterized the effects of Tacrolimus to Sirolimus conversion on frequency and function of T cells,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallon, Lorenzo, Traitanon, Opas, Sustento-Reodica, Nedjema, Leventhal, Joseph, Ansari, M. Javeed, Gehrau, Ricardo C., Ariyamuthu, Venkatesh, De Serres, Sacha A, Alvarado, Antonio, Chhabra, Darshika, Mathew, James M, Najafian, Nader, Mas, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382402/ https://www.ncbi.nlm.nih.gov/pubmed/25354238 http://dx.doi.org/10.1038/ki.2014.350

Ejemplares similares

Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells
por: Traitanon, Opas, et al.
Publicado: (2015)

Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil
por: Traitanon, Opas, et al.
Publicado: (2019)

Hyperacute Onset of Immune Checkpoint Inhibitor–Related Acute Interstitial Nephritis
por: Tawhari, Ibrahim, et al.
Publicado: (2020)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection
por: Dalal, Pranav, et al.
Publicado: (2009)

Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine
por: Silva, Jacqueline D., et al.
Publicado: (2023)

Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
por: Dalal, P, et al.
Publicado: (2010)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
por: Wagle Shukla, Aparna, et al.
Publicado: (2023)

Molecular immune monitoring in kidney transplant rejection: a state-of-the-art review
por: Chancharoenthana, Wiwat, et al.
Publicado: (2023)

Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats
por: Jin, Jian, et al.
Publicado: (2017)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
por: Li, Yi, et al.
Publicado: (2015)

Mycophenolate Mofetil Enhances the Negative Effects of Sirolimus and Tacrolimus on Rat Kidney Cell Metabolism
por: Klawitter, Jelena, et al.
Publicado: (2014)

In Vitro Interaction between Isavuconazole and Tacrolimus, Cyclosporin A, or Sirolimus against Aspergillus Species
por: Schwarz, Patrick, et al.
Publicado: (2020)

Dialysate White Blood Cell Change after Initial Antibiotic Treatment Represented the Patterns of Response in Peritoneal Dialysis-Related Peritonitis
por: Tantiyavarong, Pichaya, et al.
Publicado: (2016)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Depression and low physical activity are related to sarcopenia in hemodialysis: a single-center study
por: Yuenyongchaiwat, Kornanong, et al.
Publicado: (2021)

Simultaneous Determination of Cyclosporine A, Tacrolimus, Sirolimus, and Everolimus in Whole-Blood Samples by LC-MS/MS
por: Karapirli, Mustafa, et al.
Publicado: (2012)

Sirolimus and tacrolimus rather than cyclosporine A cause bone loss in healthy adult male rats
por: Rubert, Mercedes, et al.
Publicado: (2015)

A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
por: Mathew, James M., et al.
Publicado: (2018)

Sirolimus vs tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma?
por: Ahmed, Faiza, et al.
Publicado: (2022)

A Case of Immunotactoid Glomerulopathy with Rapid Progression to End-Stage Renal Disease
por: Jain, Shikha, et al.
Publicado: (2009)

Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults
por: Groll, Andreas H., et al.
Publicado: (2016)

Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant
por: Wijesinha, Marniker, et al.
Publicado: (2019)

Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review
por: Diaz, Natalia A., et al.
Publicado: (2021)

Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study
por: El-Agroudy, A. E., et al.
Publicado: (2017)

Autophagy in kidney transplants of sirolimus treated recipients
por: Bhayana, Sagar, et al.
Publicado: (2017)

Sirolimus in renal transplant recipients with malignancies in Germany
por: Naik, Marcel G, et al.
Publicado: (2020)

Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids
por: Kloster-Jensen, Kristine, et al.
Publicado: (2016)

BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP‐12
por: Hirsch, H. H., et al.
Publicado: (2015)

Biomarkers of disease differentiation: HCV recurrence versus acute cellular rejection
por: Gehrau, Ricardo, et al.
Publicado: (2012)

Comparable Renal Function at 6 Months with Tacrolimus Combined with Fixed-Dose Sirolimus or MMF: Results of a Randomized Multicenter Trial in Renal Transplantation
por: Van Gurp, Eveline, et al.
Publicado: (2010)

Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids
por: Tian, Yu, et al.
Publicado: (2022)

A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience
por: Anutrakulchai, Sirirat, et al.
Publicado: (2016)

Sirolimus-induced pneumonitis
por: Singh, U., et al.
Publicado: (2009)

Lymphedema attributed to sirolimus
por: Ardalan, Mohammad-Reza
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_43lgc7vgemstks6bdpkqg8itog